Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Development of Novel LNPs through High-Throughput Screening

Posted on August 2, 2025 by Vernacular
← LNP Platform Technology for Targeted mRNA Delivery
High Diversity Libraries for the Identification of Human Transferrin Receptor 1 Binders for Specific Delivery of Synthetic RNA to Skeletal Muscle Tissue In Vivo →
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #09-01, Singapore 138669
© 2026 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List